Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Lisa Levin

Why Coupa Software Is Trading Higher By Over 12%; Here Are 24 Stocks Moving Premarket

Gainers

  • Biophytis S.A. (NASDAQ:BPTS) shares rose 41.5% to $1.33 in pre-market trading after the company announced data on Covid treatment.
  • bioAffinity Technologies, Inc. (NASDAQ:BIAF) rose 26.4% to $6.81 in pre-market trading after dropping around 24% on Tuesday. The company, last week, priced its IPO at $6.125 per unit.
  • Spero Therapeutics, Inc. (NASDAQ:SPRO) shares rose 20.4% to $1.36 in pre-market trading. Spero Therapeutics shares jumped over 55% on Tuesday after the company received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr.
  • Coupa Software Incorporated (NASDAQ:COUP) rose 12.2% to $62.60 in pre-market trading as the company posted better-than-expected results for its second quarter and issued strong forecast for FY23. The company also announced a $100 million buyback program.
  • Edgio, Inc.. (NASDAQ:EGIO) rose 11.7% to $3.81 in pre-market trading. Edgio, last month, named Stephen Cumming as Chief Financial Officer and Rich Diegnan as Chief Legal Officer.
  • Baudax Bio, Inc. (NASDAQ:BXRX) rose 10.6% to $0.3330 in pre-market trading after declining over 7% on Tuesday. Baudax Bio recently announced the pricing of a $6.2 million public offering.
  • Pioneer Power Solutions, Inc. (NASDAQ:PPSI) rose 10.4% to $3.90 in pre-market trading. Pioneer Power Solutions, last month, said Q2 EPS results were down year over year.
  • CF Acquisition Corp. VI (NASDAQ:CFVI) rose 10% to $14.68 in pre-market trading after gaining around 14% on Tuesday.
  • Rigetti Computing, Inc. (NASDAQ:RGTI) rose 9.2% to $2.50 in pre-market trading after dropping 37% on Tuesday.
  • Aquestive Therapeutics, Inc. (NASDAQ:AQST) rose 8% to $1.35 in pre-market trading. Oppenheimer initiated coverage on Aquestive Therapeutics with an Outperform rating and announced a price target of $8.5.
  • Maverix Metals Inc. (NYSE:MMX) rose 7.4% to $3.64 in pre-market trading.
  • Bright Minds Biosciences Inc. (NASDAQ:DRUG) rose 7.1% to $1.97 in pre-market trading after declining around 5% on Tuesday.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.